| Company/Division name | BioTechnique |
| Parent company | BioTechnique |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 22 |
| City reshored to: | York County |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals; sterile injectable drugs |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, Under-utilized capacity |
| Government Incentive dollar amount: | 2,700,000 |
